Electroacupuncture ameliorates chronic heart failure: the role of CRH neurons in the paraventricularnucleus of the hypothalamus.

Researchers investigated whether electroacupuncture could help patients with chronic heart failure, the end stage of heart disease that carries a high risk of death. Using a rat model, scientists created heart failure by blocking a major heart artery, then applied electroacupuncture to the HT7 (Shenmen) acupoint on the wrist. The study found that electroacupuncture significantly improved heart failure symptoms and heart function. The researchers discovered that chronic heart failure causes overactivity of the sympathetic nervous system—the part of your nervous system responsible for the "fight or flight" response. This overactivity damages the heart further. Electroacupuncture worked by calming specific neurons in a brain region called the paraventricular nucleus of the hypothalamus, particularly neurons that produce corticotropin-releasing hormone (CRH). By reducing the activity of these brain cells, electroacupuncture decreased excessive sympathetic nerve signals to the heart, allowing better cardiac function and autonomic nervous system balance. The study used advanced techniques including viral tracing to map nerve connections, electrophysiology to measure brain cell activity, and genetic methods to confirm that CRH neurons were the key targets. Blood tests showed reduced stress hormone levels, and heart imaging confirmed improved pumping function. While this research was conducted in animals, it provides scientific evidence supporting acupuncture's potential role in managing cardiovascular disease and suggests a specific mechanism for how acupuncture may protect the heart. Patients interested in acupuncture for heart conditions should consult with both their cardiologist and a licensed acupuncturist experienced in cardiovascular applications.

This preclinical study investigated electroacupuncture's mechanisms in chronic heart failure using a rat model with permanent left anterior descending coronary artery ligation. EA was administered at HT7 (Shenmen). Results demonstrated significant amelioration of CHF through modulation of corticotropin-releasing hormone neurons in the paraventricular nucleus of the hypothalamus. The intervention reduced sympathetic overactivation, as evidenced by improved heart rate variability, decreased c-Fos-positive neurons in the PVN, and reduced serum norepinephrine and NT-proBNP levels. Viral tracing confirmed neural connections between the heart, HT7, and PVN. Kainic acid-induced PVN lesioning attenuated EA efficacy. Chemogenetic experiments provided mechanistic validation: inhibiting PVNCRH neurons replicated EA's cardioprotective effects, while activating these neurons negated EA benefits. Echocardiography confirmed improved left ventricular function. The study establishes that EA's cardiac benefits operate via central neuromodulation of hypothalamic CRH neurons, suppressing excessive sympathetic outflow. This provides mechanistic evidence for acupuncture in cardiovascular disease management, particularly for autonomic dysfunction in heart failure.